Schering Sues Another Generics Co. Over Clarinex

Law360, New York (November 28, 2007, 12:00 AM EST) -- Schering Corp. has added generics maker Anchen Pharmaceuticals Inc. to the long list of companies it is targeting for patent infringement to protect its hold on the $722 million annual market for allergy treatment Clarinex.

Schering filed a complaint against Irvine, Calif.-based Anchen on Tuesday in the U.S. District Court for the District of New Jersey. Schering sued more than 20 companies over Clarinex. Suits originally lodged in Florida and Michigan were transferred in to multidistrict litigation proceedings in New Jersey.

In its suit against Anchen,...
To view the full article, register now.